[Effect of thymalin on thrombocyte aggregation and the antiaggregation activity of the vascular wall in intact and thymectomized rats].
Kuznik. B I BI; Makhakova. G Ch GCh; Morozov. V G VG; Pisarevskaia. L I LI; Khavinson. V Kh VKh
Key Findings
- Thymalin reduced platelet aggregation in healthy rats.
- Removing the thymus (thymectomy) increased platelet count and their tendency to aggregate.
- Thymalin treatment normalized platelet numbers and aggregation in thymectomized rats.
Practical Outcomes
- For biohackers interested in blood health, thymalin shows promise as a tool to modulate clotting tendency, especially in contexts where thymus function might be compromised. However, the data are from animal studies only, so any human protocol would be experimental and should start with very low doses and close monitoring of clotting markers.
Summary
In rats, the peptide thymalin lowered how easily platelets clump together, which could mean less risk of unwanted blood clots. When the rats' thymus was removed, they had more platelets and those platelets stuck together more, but giving them thymalin brought those numbers back toward normal.
Abstract
Administration of immunomodulator thymalin to intact rats was shown to produce reduction of platelet aggregation ability and to exert no effect on antiaggregation activity of the aorta. Thymectomy resulted in an increase of platelet number and their aggregation ability and an increase of antiaggregation activity of the vessel wall in the rats. Thymalin administration to thymectomized rats normalizes platelet hemostasis parameters. The role of the thymus in the regulation of platelet hemostasis is discussed.
Study Information
pubmed
1986